Structural basis of the cofactor- and substrate-assisted activation of human coagulation factor IXa.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Structure

• Publication date

  2009-12-09

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.str.2009.10.011PMID 20004170
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Austrian Hemophilia Registry: design, development and set of variables

  2009cited by this paper
• Activation mechanisms of coagulation factor IX

  2009cited by this paper
• Structural identification of the pathway of long-range communication in an allosteric enzyme

  2008cited by this paper
• A note on difficult structure alignment problems

  2008cited by this paper
• Version 1.2 of the Crystallography and NMR system

  2007cited by this paper
• The influence of sodium ion binding on factor IXa activity

  2006cited by this paper
• Role of Na+ and K+ in enzyme function.

  2006cited by this paper
• Na+ site in blood coagulation factor IXa: effect on catalysis and factor VIIIa binding.

  2005cited by this paper
• The case for open-source software in drug discovery.

  2005cited by this paper
• Quantification of cation-pi interactions in protein-ligand complexes: crystal-structure analysis of Factor Xa bound to a quaternary ammonium ion ligand.

  2005cited by this paper
• Physiological fIXa Activation Involves a Cooperative Conformational Rearrangement of the 99-Loop*

  2003cited by this paper
• Analysis of haemophilia B database and strategies for identification of common point mutations in the factor IX gene

  2003cited by this paper
• Redesigning the monovalent cation specificity of an enzyme

  2003cited by this paper
• Metal-ligand geometry relevant to proteins and in proteins: sodium and potassium.

  2002cited by this paper
• Crystal structures of uninhibited factor VIIa link its cofactor and substrate-assisted activation to specific interactions.

  2002cited by this paper
• Thermodynamic Linkage between the S1 Site, the Na+ Site, and the Ca2+ Site in the Protease Domain of Human Activated Protein C (APC)

  2002cited by this paper
• Factor IXa:Factor VIIIa Interaction

  2001cited by this paper
• Geometry of metal-ligand interactions in proteins.

  2001cited by this paper
• The factor VII zymogen structure reveals reregistration of beta strands during activation.

  2001cited by this paper
• Factor IX Denver, ASN 346→ASP Mutation Resulting in a Dysfunctional Protein with Defective Factor VIIIa Interaction

  2001cited by this paper
• Structure of a serpin–protease complex shows inhibition by deformation

  2000cited by this paper
• Preparation, characterization, and the crystal structure of the inhibitor ZK-807834 (CI-1031) complexed with factor Xa.

  2000cited by this paper
• Thermodynamic Linkage between the S1 Site, the Na+Site, and the Ca2+ Site in the Protease Domain of Human Coagulation Factor Xa

  2000cited by this paper
• Insertion loop 256-268 in coagulation factor IX restricts enzymatic activity in the absence but not in the presence of factor VIII.

  2000cited by this paper
• Coagulation factor IXa: the relaxed conformation of Tyr99 blocks substrate binding.

  1999cited by this paper
• The A2 Subunit of Factor VIIIa Modulates the Active Site of Factor IXa*

  1998cited by this paper
• Converting blood coagulation factor IXa into factor Xa: dramatic increase in amidolytic activity identifies important active site determinants

  1997cited by this paper
• MOLREP: an Automated Program for Molecular Replacement

  1997cited by this paper
• Interaction of Factor IXa with Factor VIIIa

  1997cited by this paper
• Dramatic enhancement of the catalytic activity of coagulation factor IXa by alcohols

  1997cited by this paper
• X-ray Structure of Active Site-inhibited Clotting Factor Xa

  1996cited by this paper
• Residue 225 determines the Na(+)-induced allosteric regulation of catalytic activity in serine proteases.

  1996cited by this paper
• Cleavage at Arginine 145 in Human Blood Coagulation Factor IX Converts the Zymogen into a Factor VIII Binding Enzyme (*)

  1995cited by this paper
• X-ray structure of clotting factor IXa: active site and module structure related to Xase activity and hemophilia B.

  1995cited by this paper
• The CCP4 suite: programs for protein crystallography.

  1994cited by this paper
• Importance of Substrate Composition, pH and Other Variables on Tissue Factor Enhancement of Factor Vlla Activity

  1993cited by this paper
• Analysis of the functions of the first epidermal growth factor-like domain of factor X.

  1993cited by this paper
• Antibody-probed conformational transitions in the protease domain of human factor IX upon calcium binding and zymogen activation: putative high-affinity Ca(2+)-binding site in the protease domain.

  1992cited by this paper
• The active site of factor IXa is located far above the membrane surface and its conformation is altered upon association with factor VIIIa. A fluorescence study.

  1992cited by this paper
• The refined 1.9 A crystal structure of human alpha‐thrombin: interaction with D‐Phe‐Pro‐Arg chloromethylketone and significance of the Tyr‐Pro‐Pro‐Trp insertion segment.

  1989cited by this paper
• Degradation of coagulation proteins by an enzyme from Malayan pit viper (Akistrodon rhodostoma) venom.

  1987cited by this paper
• Derivatives of blood coagulation factor IX contain a high affinity Ca2+-binding site that lacks gamma-carboxyglutamic acid.

  1984cited by this paper
• Active-site mapping of bovine and human blood coagulation serine proteases using synthetic peptide 4-nitroanilide and thio ester substrates.

  1984cited by this paper
• Cleavage and activation of human factor IX by serine proteases.

  1984cited by this paper
• Reactivity of bovine blood coagulation factor IXa beta, factor Xa beta, and factor XIa toward fluorogenic peptides containing the activation site sequences of bovine factor IX and factor X.

  1983cited by this paper
• Isolation and characterization of a cDNA coding for human factor IX.

  1982cited by this paper
• The interaction of Ca2+ with human Factor IX.

  1981cited by this paper
• The role of phospholipid and factor VIIIa in the activation of bovine factor X.

  1981cited by this paper
• Mapping the active sites of bovine thrombin, factor IXa, factor Xa, factor XIa, factor XIIa, plasma kallikrein, and trypsin with amino acid and peptide thioesters: development of new sensitive substrates.

  1981cited by this paper
• A kinetic evaluation of activated bovine blood coagulation factor IX toward synthetic substrates.

  1980cited by this paper
• Activation of bovine factor IX (Christmas factor) by factor XIa (activated plasma thromboplastin antecedent) and a protease from Russell's viper venom.

  1978cited by this paper
• Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation.

  1977cited by this paper
• The mechanism of activation of bovine factor IX (Christmas factor) by bovine factor XIa (activated plasma thromboplastin antecedent).

  1974cited by this paper
• Interaction of tissue factor and factor VII at the earliest phase of coagulation.

  1965cited by this paper

• Blood Coagulation Factor IX: Structure, Function, and Regulation

  2025cites this paper
• The Construction of a Molecular Model for the Ternary Protein Complex of Intrinsic Coagulation Pathway Factors Provides Novel Insights for the Pathogenesis of Cross-Reactive Material Positive Coagulation Factor Mutations

  2025cites this paper
• Design and synthesis of novel fucosylated chondroitin sulfate derivatives as intrinsic FXase inhibitors and evaluation of their antithrombotic activities.

  2025cites this paper
• Chiral sodium complex–catalyzed asymmetric cascade cycloaddition/hydration/1,2-rearrangement

  2025cites this paper
• Pleiotropic Effects of Different Exonic Nucleotide Changes at the Same Position Contributing to Hemophilia B Phenotypic Variation.

  2024cites this paper
• Membrane-Dependent Reactions of Blood Coagulation: Classical View and State-of-the-Art Concepts

  2024cites this paper
• Docking-based computational analysis of guava (Psidium guajava) leaves derived bioactive compounds as a coagulation factor IXa inhibitor

  2024cites this paper
• An RNA aptamer exploits exosite-dependent allostery to achieve specific inhibition of coagulation factor IXa

  2024cites this paper
• Humanization and functional characterization of enhanced coagulation factor IX variants identified through ancestral sequence reconstruction.

  2023cites this paper
• Crippling down factor IX for therapeutic gain.

  2023cites this paper
• Structural insights into blood coagulation factor VIII: Procoagulant complexes, membrane binding, and antibody inhibition

  2022cites this paper
• A systematic approach for evaluating the role of surface-exposed loops in trypsin-like serine proteases applied to the 170 loop in coagulation factor VIIa

  2022cites this paper
• SAXS analysis of the intrinsic tenase complex bound to a lipid nanodisc highlights intermolecular contacts between factors VIIIa/IXa

  2022cites this paper
• Blood Coagulation Factor IX: Purification, Isolation, Activation Blood Coagulation Factor IX: Purification, Isolation, Activation

  2022cites this paper
• Blood Coagulation Factor IX: Purification, Isolation, Activation Blood Coagulation Factor IX: Purification, Isolation, Activation

  2022cites this paper
• The Molecular Basis of FIX Deficiency in Hemophilia B

  2022influential citation
• Probing activation‐driven changes in coagulation factor IX by mass spectrometry

  2021cites this paper
• A factor VIIIa – mimetic bispecific antibody, Mim8, ameliorates bleeding upon severe vascular challenge in hemophilia A mice

  2021cites this paper
• Coagulation factor IX analysis in bioreactor cell culture supernatant predicts quality of the purified product

  2021cites this paper
• SAXS analysis of intrinsic tenase complex bound to lipid nanodisc highlights intermolecular contacts between factors VIIIa/IXa

  2021cites this paper
• A factor VIIIa–mimetic bispecific antibody, Mim8, ameliorates bleeding upon severe vascular challenge in hemophilia A mice

  2021cites this paper
• Mapping the zymogen to protease transition in FIXa

  2021cites this paper
• Coagulation factor IX analysis in bioreactor cell culture supernatant predicts quality of the purified product

  2021cites this paper
• Factor VIII-driven changes in activated Factor IX explored by Hydrogen-Deuterium eXchange Mass Spectrometry.

  2020cites this paper
• Exosite binding drives substrate affinity for the activation of coagulation factor X by the intrinsic Xase complex

  2020cites this paper
• Plasmin‐mediated proteolysis of human factor IXa in the presence of calcium/phospholipid: Conversion of procoagulant factor IXa to a fibrinolytic enhancer

  2020cites this paper
• Analysis of coagulation factor IX in bioreactor cell culture medium predicts yield and quality of the purified product

  2020cites this paper
• Maturation of coagulation factor IX during Xase formation as deduced using factor VIII‐derived peptides

  2019cites this paper
• Sirtilins – the new old members of the vitamin K‐dependent coagulation factor family

  2019cites this paper
• An improved yeast surface display platform for the screening of nanobody immune libraries

  2019cites this paper
• Sodium‐site in serine protease domain of human coagulation factor IXa: evidence from the crystal structure and molecular dynamics simulations study

  2019cites this paper
• Crystal structure and substrate-induced activation of ADAMTS13

  2019cites this paper
• Surface loops of trypsin-like serine proteases as determinants of function.

  2019cites this paper
• CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR IXa

  2019cites this paper
• Elevated Plasma Factor IXa Activity in Premenopausal Women on Hormonal Contraception

  2018cites this paper
• Structural determinants of specificity and regulation of activity in the allosteric loop network of human KLK8/neuropsin

  2018cites this paper
• Mutational Profiles of F8 and F9 in a Cohort of Haemophilia A and Haemophilia B Patients in the Multi-ethnic Malaysian Population

  2018cites this paper
• FUNCTIONAL STUDIES WITH DIRECT ORAL ANTICOAGULANTS: INVESTIGATION OF THE REGULATION OF KEY BLOOD COAGULATION PROTEASES

  2016cites this paper
• Releasing the brakes in coagulation Factor IXa by co-operative maturation of the substrate-binding site.

  2016cites this paper
• Coagulation factor IX regulates cell migration and adhesion in vitro

  2015cites this paper
• Quantifying vitamin K-dependent holoprotein compaction caused by differential γ-carboxylation using high-pressure size exclusion chromatography.

  2015cites this paper
• Molecular Basis of Enhanced Activity in Factor VIIa-Trypsin Variants Conveys Insights into Tissue Factor-mediated Allosteric Regulation of Factor VIIa Activity*

  2015cites this paper
• Selective disruption of heparin and antithrombin‐mediated regulation of human factor IX

  2015cites this paper
• Next generation FIX muteins with FVIII‐independent activity for alternative treatment of hemophilia A

  2014cites this paper
• N-terminal protein modification by substrate-activated reverse proteolysis.

  2014cites this paper
• Expression of Recombinant Coagulation Factor IX in Human Amniotic Membrane-derived Mesenchymal Stem Cells: A New Strategy to Gene Therapy of Hemophilia B

  2014cites this paper
• N‐terminale Proteinmodifizierung mittels Substrat‐aktivierter Katalyse

  2014cites this paper
• A comprehensive Hemophilia Interaction Network Model

  2014cites this paper
• Pharmacokinetic Characterization of Procoagulation Proteins

  2014cites this paper
• The activation peptide of coagulation factor IX and X serves as a high affinity receptor to cationic ligands

  2013cites this paper
• Coagulation Factor IXa

  2013cites this paper
• An interactive mutation database for human coagulation factor IX provides novel insights into the phenotypes and genetics of hemophilia B

  2013cites this paper
• Residues of the 39-Loop Restrict the Plasma Inhibitor Specificity of Factor IXa*

  2013cites this paper
• Crystal Structures of the Viral Protease Npro Imply Distinct Roles for the Catalytic Water in Catalysis

  2013cites this paper
• phenotype in mice Engineered factor IX variants bypass FVIII and correct hemophilia A

  2013cites this paper
• Coagulation factor VIII: its molecular structure and functional mechanism

  2013cites this paper
• Do-it-yourself histidine-tagged bovine enterokinase: A handy member of the protein engineer's toolbox

  2013cites this paper
• Measurement and analysis of NMR residual dipolar couplings for the study of intrinsically disordered proteins.

  2012cites this paper
• FIXing factor VIII inhibitors.

  2012cites this paper
• Engineered Factor VII, Factor IX, and Factor X Variants for Hemophilia Gene Therapy

  2012cites this paper
• Correlation of factor IXa subsite modulations with effects on substrate discrimination

  2012cites this paper
• Engineered factor IX variants bypass FVIII and correct hemophilia A phenotype in mice.

  2012cites this paper
• Complex assemblies of factors IX and X regulate the initiation, maintenance, and shutdown of blood coagulation.

  2011cites this paper
• Rigidification of the autolysis loop enhances Na(+) binding to thrombin.

  2011cites this paper
• Thrombin as an anticoagulant.

  2011cites this paper
• Thrombin as an anticoagulant.

  2011cites this paper
• Evidence of the E*-E equilibrium from rapid kinetics of Na+ binding to activated protein C and factor Xa.

  2010cites this paper